Page last updated: 2024-08-21

fluorobenzenes and Complication, Postoperative

fluorobenzenes has been researched along with Complication, Postoperative in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	6 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biondi-Zoccai, G; Calcagno, S; Canali, E; Conti, G; Fedele, F; Lucisano, L; Mancone, M; Pennacchi, M; Sardella, G; Stio, RE	1
Aydogdu, S; Canpolat, U; Cay, S; Durmaz, T	1
Qu, Y; Xia, J; Xu, D; Yin, C	1
Colivicchi, F	1
Burtseva, EA; Goloviuk, AL; Ivanov, LO; Kuntsevich, GI; Pokrovskiĭ, AV; Suntsov, DS; Zotikov, AE	1
Arnaoutoglou, EM; Bairaktari, ET; Gartzonika, C; Kostara, C; Kouvelos, GN; Matsagkas, MI; Milionis, HJ	1
Dai, H; Ge, Z; Hou, F; Lin, X; Ma, Y; Ren, Y; Tan, K; Wang, S; Wang, Y; Wang, Z; Xing, M; Yu, Z; Zhang, J	1
Frolich, J; Humphries, K; Ignaszewski, A; Imai, C; Samman, A; Straatman, L	1

Trials

4 trial(s) available for fluorobenzenes and Complication, Postoperative

Article	Year
Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial. International journal of cardiology, 2013, Oct-09, Volume: 168, Issue:4 Topics: Aged; Angina, Stable; Atorvastatin; Elective Surgical Procedures; Female; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Myocardial Infarction; Necrosis; Percutaneous Coronary Intervention; Postoperative Complications; Preoperative Care; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2013
Preoperative rosuvastatin protects patients with coronary artery disease undergoing noncardiac surgery. Cardiology, 2015, Volume: 131, Issue:1 Topics: Aged; Coronary Artery Disease; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Preoperative Care; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2015
Effects of rosuvastatin with or without ezetimibe on clinical outcomes in patients undergoing elective vascular surgery: results of a pilot study. Journal of cardiovascular pharmacology and therapeutics, 2013, Volume: 18, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Azetidines; C-Reactive Protein; Cholesterol, LDL; Drug Therapy, Combination; Elective Surgical Procedures; Ezetimibe; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vascular Surgical Procedures	2013
Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes. Journal of cardiovascular pharmacology and therapeutics, 2013, Volume: 18, Issue:4 Topics: Acute Coronary Syndrome; Aged; C-Reactive Protein; Chemokine CCL2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Postoperative Complications; Preoperative Care; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2013

Other Studies

4 other study(ies) available for fluorobenzenes and Complication, Postoperative

Article	Year
High dose statins should be used in all patients undergoing percutaneous coronary intervention. International journal of cardiology, 2013, Oct-12, Volume: 168, Issue:5 Topics: Elective Surgical Procedures; Female; Fluorobenzenes; Heptanoic Acids; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Postoperative Complications; Pyrimidines; Pyrroles; Sulfonamides	2013
Statin reloading before noncardiac surgery: a simple, safe and effective approach for reducing the risk of perioperative myocardial infarction. Cardiology, 2015, Volume: 131, Issue:1 Topics: Coronary Artery Disease; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Postoperative Complications; Pyrimidines; Sulfonamides	2015
[Rosuvastatin in prevention of cardiac complications following surgical treatment of patients with vascular pathology]. Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 2009, Volume: 15, Issue:3 Topics: Adult; Aged; Aorta, Abdominal; Atherosclerosis; Brachiocephalic Trunk; Dose-Response Relationship, Drug; Embolism, Cholesterol; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Postoperative Complications; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome; Vascular Surgical Procedures	2009
Safety and efficacy of rosuvastatin therapy for the prevention of hyperlipidemia in adult cardiac transplant recipients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:8 Topics: Aged; Aged, 80 and over; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorobenzenes; Follow-Up Studies; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Hyperlipidemias; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pyrimidines; Risk Assessment; Rosuvastatin Calcium; Sulfonamides; Survival Rate; Treatment Outcome	2005